Nothing Is Undruggable: Novartis' Bradner On CAR-T, CRISPR & DNA Libraries

 
• By Sten Stovall

The head of Novartis' early drug discovery engine NIBR has a zealous sense of mission and says he is being given the resources and talent to accomplish it. "Nothing is undruggable," is his premise.

James Bradner, President of the Novartis Institutes for BioMedical Research (NIBR)
James Bradner, President, Novartis Institutes for BioMedical Research (NIBR) • Source: Novartis AG

More from R&D

More from Scrip